PURPOSE OF REVIEW: Sub-Saharan Africa has the largest population of people living with AIDS in the world, with Nigeria having the third largest after South Africa and India. With the advent of treatment programs, more people in Nigeria are now living with the virus but are at increased risk of cancer similar to the experience in other parts of the world. This review uses publications on HIV-associated cancers emanating from Nigeria in 2008 to map the current landscape of prevention, diagnosis and treatment of these conditions. The opportunities and challenges identified in this review will provide a template for designing appropriate clinical and public health intervention to stem another epidemic, this time of AIDS-associated malignancies. RECENT FINDINGS: There is a paucity of literature on AIDS-associated cancers from Nigeria, and most reports are based on hospital or pathology case series. Poor case identification and diagnosis and rudimentary cancer registration militate against adequate quantification of the prevalence of AIDS-associated cancers in Nigeria. Several initiatives, working with the HIV treatment programs, governmental and nongovernmental local and international agencies, are rising to the challenge and creating new opportunities for cancer prevention, treatment and research that takes advantage of improved treatment infrastructure provided for people living with HIV/AIDS. SUMMARY: Nigeria is about to witness substantial increase in the background incidence of cancers due to high prevalence of HIV and expanded treatment programs. Creative methods are needed to deploy effective prevention, case identification, registration and treatment programs that are consistent with the socioeconomic development of the country.
PURPOSE OF REVIEW: Sub-Saharan Africa has the largest population of people living with AIDS in the world, with Nigeria having the third largest after South Africa and India. With the advent of treatment programs, more people in Nigeria are now living with the virus but are at increased risk of cancer similar to the experience in other parts of the world. This review uses publications on HIV-associated cancers emanating from Nigeria in 2008 to map the current landscape of prevention, diagnosis and treatment of these conditions. The opportunities and challenges identified in this review will provide a template for designing appropriate clinical and public health intervention to stem another epidemic, this time of AIDS-associated malignancies. RECENT FINDINGS: There is a paucity of literature on AIDS-associated cancers from Nigeria, and most reports are based on hospital or pathology case series. Poor case identification and diagnosis and rudimentary cancer registration militate against adequate quantification of the prevalence of AIDS-associated cancers in Nigeria. Several initiatives, working with the HIV treatment programs, governmental and nongovernmental local and international agencies, are rising to the challenge and creating new opportunities for cancer prevention, treatment and research that takes advantage of improved treatment infrastructure provided for people living with HIV/AIDS. SUMMARY: Nigeria is about to witness substantial increase in the background incidence of cancers due to high prevalence of HIV and expanded treatment programs. Creative methods are needed to deploy effective prevention, case identification, registration and treatment programs that are consistent with the socioeconomic development of the country.
Authors: Bukola F Adeyemi; Lola V Adekunle; Bamidele M Kolude; Effiong E U Akang; Jonathan O Lawoyin Journal: J Natl Med Assoc Date: 2008-06 Impact factor: 1.798
Authors: J J Goedert; T R Coté; P Virgo; S M Scoppa; D W Kingma; M H Gail; E S Jaffe; R J Biggar Journal: Lancet Date: 1998-06-20 Impact factor: 79.321
Authors: Chen Reis; Michele Heisler; Lynn L Amowitz; R Scott Moreland; Jerome O Mafeni; Chukwuemeka Anyamele; Vincent Iacopino Journal: PLoS Med Date: 2005-07-19 Impact factor: 11.069
Authors: L Dal Maso; J Polesel; D Serraino; M Lise; P Piselli; F Falcini; A Russo; T Intrieri; M Vercelli; P Zambon; G Tagliabue; R Zanetti; M Federico; R M Limina; L Mangone; V De Lisi; F Stracci; S Ferretti; S Piffer; M Budroni; A Donato; A Giacomin; F Bellù; M Fusco; A Madeddu; S Vitarelli; R Tessandori; R Tumino; B Suligoi; S Franceschi Journal: Br J Cancer Date: 2009-02-17 Impact factor: 7.640
Authors: Elima Jedy-Agba; Maria Paula Curado; Olufemi Ogunbiyi; Emmanuel Oga; Toyin Fabowale; Festus Igbinoba; Gloria Osubor; Theresa Otu; Henry Kumai; Alice Koechlin; Patience Osinubi; Patrick Dakum; William Blattner; Clement A Adebamowo Journal: Cancer Epidemiol Date: 2012-05-22 Impact factor: 2.984
Authors: Elima E Jedy-Agba; Maria-Paula Curado; Emmanuel Oga; Modupeola O Samaila; Emmanuel R Ezeome; Christopher Obiorah; Olagoke O Erinomo; Ima-Obong A Ekanem; Cornelius Uka; Ahmed Mayun; Enoch A Afolayan; Popoola Abiodun; Babatunde J Olasode; Abidemi Omonisi; Theresa Otu; Patience Osinubi; Patrick Dakum; William Blattner; Clement A Adebamowo Journal: Cancer Epidemiol Date: 2012-06-15 Impact factor: 2.984
Authors: Agnes Moses; Albert Mwafongo; Maria Chikasema; Laureen Kafantenganji; Christopher Stanely; Emma Chimzukira; Coxcilly Kampani; Robert Krysiak; Satish Gopal; Nora E Rosenberg; Carol G Shores; Mina C Hosseinipour Journal: Malawi Med J Date: 2017-06 Impact factor: 0.875
Authors: Elima E Jedy-Agba; Emmanuel A Oga; Michael Odutola; Yusuf M Abdullahi; Abiodun Popoola; Peter Achara; Enoch Afolayan; Adekunbiola Aina Fehintola Banjo; Ima-Obong Ekanem; Olagoke Erinomo; Emmanuel Ezeome; Festus Igbinoba; Christopher Obiorah; Olufemi Ogunbiyi; Abidemi Omonisi; Clement Osime; Cornelius Ukah; Patience Osinubi; Ramatu Hassan; William Blattner; Patrick Dakum; Clement A Adebamowo Journal: Front Public Health Date: 2015-07-30
Authors: Saidu I Ngulde; Francis Fezeu; Arjun Ramesh; Shayan Moosa; Benjamin Purow; Beatrice Lopez; David Schiff; Isa M Hussaini; Umar K Sandabe Journal: Cureus Date: 2015-11-03